Login / Signup

Susceptibility Vessel Sign and Cardioembolic Etiology in the THRACE Trial.

Romain BourcierImad DerrazBéatrice DelasalleMarine BeaumontSebastien SoizeLaurence LegrandHubert DesalSerge BracardOlivier NaggaraCatherine Oppenheimnull null
Published in: Clinical neuroradiology (2018)
The presence of SVS is associated to CE, independent of GRE sequence parameters. While the specificity and the PPV of the sign were low, CE seems less likely in the absence of an SVS.
Keyphrases
  • energy transfer
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • open label
  • amino acid
  • double blind